Revolution Medicines, Inc 10-Q for FY2023 Q1
Revolution Medicines, Inc. (RVMD)
10-Q
2023-05-08
For: 2023-03-31
View Original
Added on
April 10, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on May 8, 2023, covering the quarter ended March 31, 2023 (FY2023 Q1).
Headline figures
Quarter ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $7.01M
- down 7.4% from $7.58M a year earlier
- Net loss
- $68.1M
- compared with a net loss of $57.65M a year earlier
- Diluted EPS
- -$0.72
- compared with -$0.78 a year earlier